Paper7928673
Dorrigocins: novel antifungal antibiotics that change the morphology of ras-transformed NIH/3T3 cells to that of normal cells. III. Biological properties and mechanism of action.
Kadam S and 1 other. J Antibiot (Tokyo), 1994. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. Dorrigocins: novel antifungal antibiotics that change the morphology of ras-transformed NIH/3T3 cells to that of normal cells. III. Biological properties and mechanism of action. Papers, record 7928673. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7928673
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Dorrigocins: novel antifungal antibiotics that change the morphology of ras-transformed NIH/3T3 cells to that of normal cells. III. Biological properties and mechanism of action.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| 3T3 Cells | Major topic |
| Alkyl and Aryl Transferases | Major topic |
| Antifungal Agents | Major topic |
| Cell Transformation, Neoplastic | Major topic |
| Genes, ras | Major topic |
| Animals | |
| Mating Factor | |
| Methylation | |
| Mice | |
| Oncogene Protein p21(ras) | |
| Peptides | |
| Piperidones | |
| Protein Biosynthesis | |
| Protein O-Methyltransferase | |
| Signal Transduction | |
| Transferases |
Source PubMed
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38345531 | Discrete Acyltransferases and Thioesterases in Iso-Migrastatin and Lactimidomycin Biosynthesis. | Biochemistry | 2024 | https://conductscience.org/library/papers/38345531 | PubMed |
| 25405956 | Comparative characterization of the lactimidomycin and iso-migrastatin biosynthetic machineries revealing unusual features for acyltransferase-less type I polyketide synthases and providing an opportunity to engineer new analogues. | Biochemistry | 2014 | https://conductscience.org/library/papers/25405956 | PubMed |
| 23394593 | Post-polyketide synthase steps in iso-migrastatin biosynthesis, featuring tailoring enzymes with broad substrate specificity. | J Am Chem Soc | 2013 | https://conductscience.org/library/papers/23394593 | PubMed |
| 20806307 | Multifaceted modes of action for the glutarimide-containing polyketides revealed. | Chembiochem | 2010 | https://conductscience.org/library/papers/20806307 | PubMed |
| 20118940 | Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin. | Nat Chem Biol | 2010 | https://conductscience.org/library/papers/20118940 | PubMed |
| 18684620 | Evaluation of new migrastatin and dorrigocin congeners unveils cell migration inhibitors with dramatically improved potency. | Bioorg Med Chem Lett | 2008 | https://conductscience.org/library/papers/18684620 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7928673
GET https://conductscience.org/api/papers/v1/7928673/authors